Effect of glycyrrhizin on traumatic brain injury in rats and its mechanism

Chinese Journal of Traumatology - English Edition

Volumn 17, Issue 1, 2014, Pages 1-7

  Xiangjin, Gu ^a   Jin, Xu ^a   Banyou, Ma ^a   Gong, Chen ^a   Peiyuan, Gu ^a   Dong, Wei ^a   Weixing, Hu ^b  

^a THE AFFILIATED JIANGNING HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Brain injuries; Glycyrrhizic acid; HMGB1 protein; Neuroprotective agents

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GLYCYRRHIZIC ACID; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TOLL LIKE RECEPTOR 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; IMMUNOHISTOCHEMISTRY; MALE; MOTOR PERFORMANCE; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN DNA BINDING; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; RAT MODEL; REAL TIME POLYMERASE CHAIN REACTION; SCORING SYSTEM; SIGNAL TRANSDUCTION; TRAUMATIC BRAIN INJURY; WALKING;

ANIMALS; BRAIN INJURIES; GLYCYRRHIZIC ACID; HMGB1 PROTEIN; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84906054083     PISSN: 10081275     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1008-1275.2014.01.001     Document Type: Article

References (24)

1. Greve MW, Zink BJ. Pathophysiology of traumatic brain injury [J], Mt Sinai J Med 2009;76(2):97-104.
2. Cederberg D, Siesjo P. What has inflammation to do with traumatic brain injury [J]? Childs Nerv Syst 2010;26(2):221-6.
3. Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal [J]. Nat Rev Immunol 2005;5(4):331-42.
4. Sims GP, Rowe DC, Rietdijk ST, et al. HMGB 1 and RAGE in inflammation and cancer [J], Annu Rev Immunol 2010;28:367-88.
5. Park JS, Gamboni-Robertson F, He Q, et al. High mobility group box 1 protein interacts with multiple Toll-like receptors [J], Am J Physiol Cell Physiol 2006;290(3):C917-24.
6. Luan ZG, Zhang H, Yang PT, et al. HMGB 1 activates nuclear factor- K B signaling by RAGE and increases the production of TNF- α in human umbilical vein endothelial cells [J]. Immunobiology 2010;215(12):956-62.
7. Kawai T, Akira S. TLR signaling [J], Semin Immunol 2007; 19(1):24-32.
8. Au AK, Aneja RK, Bell MJ, et al. Cerebrospinal fluid levels of high-mobility group box 1 and cytochrome C predict outcome after pediatric traumatic brain injury [J]. J Neurotrauma 2012;29 (11):2013-21.
9. Wang KY, Yu GF, Zhang ZY, et al. Plasma high-mobility group box 1 levels and prediction of outcome in patients with traumatic brain injury [J]. Clin Chim Acta 2012;413(21-22):1737-41.
10. Mollica L, De Marchis F, Spitaleri A, et al. Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities [J], Chem Biol 2007;14(4):431-41.
11. Feeney DM, Boyeson MG, Linn RT, et al. Responses to cortical injury: I. Methodology and local effects of contusions in the rat [J], Brain Res 1981;211(1): 67-77.
12. Chen SF, Hsu CW, Huang WH, et al. Post-injury baicalein improves histological and functional outcomes and reduces in-flammatory cytokines after experimental traumatic brain injury [J], Br J Pharmacol 2008;155(8):1279-96.
13. Roof RL, Duvdevani R, Heyburn JW, et al. Progesterone rapidly decreases brain edema: treatment delayed up to 24 hours is still effective [J]. Exp Neurol 1996;138(2):246-51.
14. Morganti-Kossmann MC, Rancan M, Otto VI, et al. Role of cerebral inflammation after traumatic brain injury: a revisited concept [J]. Shock 2001;16(3):165-77.
15. van Rossum TG, Vulto AG, Hop WC, et al. Glycyrrhizin-induced reduction of ALT in European patients with chronic hepatitis C [J]. Am J Gastroenterol 2001;96(8):2432-7.
16. Kim SW, Jin Y, Shin JH, et al. Glycyrrhizic acid affords robust neuroprotection in the postischemic brain via anti-inflam- matory effect by inhibiting HMGB1 phosphorylation and secretion [J]. Neurobiol Dis 2012;46(1):147-56.
17. Ohnishi M, Katsuki H, Fukutomi C, et al. HMGB1 inhibitor glycyrrhizin attenuates intracerebral hemorrhage-induced injury in rats [J]. Neuropharmacology 2011;61(5-6):975-80.
18. Gong G, Yuan LB, Hu L, et al. Glycyrrhizin attenuates rat ischemic spinal cord injury by suppressing inflammatory cytokines and HMGBl [J]. Acta Pharmacologica Sin 2012;33(1):11-8.
19. Zhu S, Li W, Ward MF, et al. High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation [J]. Inflamm Allergy Drag Targets 2010;9(1):60-72.
20. Cohen MJ, Brohi K, Calfee CS, et al. Early release of high mobility group box nuclear protein 1 after severe trauma in humans: role of injury severity and tissue hypoperfusion [J]. Crit Care 2009;13(6):R174.
21. Okuma Y, Liu K, Wake H, et al. Anti-high mobility group box-1 antibody therapy for traumatic brain injury [J]. Ann Neurol 2012;72(3):373-84.
22. Monder C, Stewart PM, Lakshmi V, et al. Licorice inhibits corticosteroid 11 beta-dehydrogenase of rat kidney and liver: in vivo and in vitro studies [J]. Endocrinology 1989; 125(2): 1046-53.
23. Oh YJ, Youn JH, Ji Y, et al. HMGB1 is phosphorylated by classical protein kinase C and is secreted by a calcium-dependent mechanism [J]. J Immunol 2009;182(9):5800-9.
24. Imtiaz KE. Sweet root, bitter pill: liquorice-induced hyperaldosteronism [J]. QJM 2011;104(12): 1093-5.